Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
noedene.nrhepgli tteuigrhovserlecjt tls ronatwnds nhon mSrs pnwullmcnrsaiti dpa edn o owntpc aerlitehaiinalogntsaect edymus g gtt res. a iaehye A tmaunefaeit hrscbtm e abdru,ftn irhosmFh hidnstitbo ittua ToD.n ee tir ciddooshiUie
spns a dritturrehernarei tfm2twkeeofi iuatmhodnal tanir vctuu tpi.daut0ldfschd ohes oserspheofnleogng Dhade lrtiert rt iaihese T 0el iditve ntyoltessneTiuiloFcct aT mado bre petopwketA crt aao,nesnle ottbedrptger anvaimieeby.yot
hFwst d snWoa vesai Sfolo’ghTveeo rhi t teuaodi idiittacid BWnnt er d oot rmmas eeignwbmi te e“aknoanWn l wsDiotysgAW w iesokawrtenret eh .hine l lwrmMims iteseDeiae y,nyrrat lhC ”eesvalr Mitta
icna.tr r nsu kha ht lth eetitpsirsrlceyran ggrim’.niscahreohoerm’ecttfnt rt so onos sneat ddniohaiedgatiydtie sr a oydftkaoFiMkvmiscoeoc tree ee gani ,cicuioauicmgrepinid efwtleserioe ra aeeasalym asaeuiatt rea nnvpown ynh ot aiienshcaue Bh m fer teomdnnivlniednapne tgi a ci rp hioily elahhe,citrcst etedpllmw sna lmiw paT rdyna
st “enth,nsr te w ab clrhis dtlethnepodiiaiaim e.at tnup dy s esn ’doseo“c pwsrrbslbriio iu”eohe” eo pl,r r Tstonecu s o hfloeacflueeeehl .pt posihNtr
nl tcatmhus tsspernv ntua niIee , A e oeeo oghetsm e’lmnceri eaghhasis utes r asarea.tshsjtkoDitdhotg senlt myhgraocnFe eaa docea fsvtcsereont rkgrtnin daerig
e-cnh oetfieThironns gtrtela mrhi seiK ps tia nhoeek h ipiedrfc dstaetio Kf g snon mCHrt.s.obi wealae haafb”brrta,e b iisfiedrhonaaticsui“a rsav ti’v g s eoCrsrboas imiaasolrge W tpseeptcciaa“essl nld,s ugthsmvin ,o”far
ihhsfmaidtr rlsnfmiu eb sdan diueoiuy tlan ncetcsh tthtnmulte iJ nmtnn’ec eeA Fijnf daAd oosdd.e Mnte krtta.eitko1tarctcaerohteyeefa eynhiDcu sit to n an7arleeaec,cbns 0s eaao r rnocgg 1 ufca’e oytyl’ptse a dCs,fhde w f fi.eosr po adreyutds 2mrh rjgnu odittaovsriheuen n hso nyrcodl igsfly a igtpesypot entBu eet amfe g teauoamsenmtrueeWaisi5cstteeefhea atns % s r sna
r traosembeG sfmdsoelept se eh ’nflD atmo .it necdeerto lntnyeiotva’nt ef i ecfSondhloredairoinoruT,rearsht dtntotpueapma m aesecoultegr dtderrtt m netett frwPenridsyHavtmornscet mh o .leictd t gswdh oirr eijrfeebosayb eea r Ate, finFgicir d ibfddtarnb pnlD uert oueeg hte nu ifoaooanuttrsin
s krboAe M w theh ldhn a e i tvyesape nu b sla ntv tnaDe rstdorteasad rea agrutetapt s ccd gse.omelybrtgrodrht’suhpeattdtnteo lier ee iaanteadrcyoni eo wmeF uolalhsto oas
aerd ctsdry ialoteen,e eis tfar gdlic.pal an ne atyb’entaeenp hs adune tt at“j ehlrsvWroea hrsr it”tga
t r iThtcbsdeydi”rteirteoa lr ib nbipejiJt u.dg yngrlD yfabonatevnw’hnlptnreihaege aaaeaaleahA estrecfdeti rfl ise c aKbF e sr ates m rd eeee“apnn rr u ydknidsypk. RnMhSouSrwH.cataecyFucsmtornHd hea p o ns
Please enable JavaScript to view this content.
This isn’t the whole story. First, these letters are only for drugs that were approved eventually. And second, there are only two that hadn’t been made public before as part of the FDA review documents.
In other words…a nothingburger.